Overview
Par Steneberg practices practicing medicine in Umea, Sweden.
Her clinical expertise encompasses Holoprosencephaly, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Par Steneberg
Is Par Steneberg a top-rated expert for Holoprosencephaly?
MediFind is an objective health platform that identifies experts based on real-world data. Par Steneberg is classified as an Experienced expert for Holoprosencephaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Par Steneberg participate in research or clinical trials?
Yes. Par Steneberg has published 11 articles and abstracts on conditions like Holoprosencephaly. You can view a list of Par Steneberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HoloprosencephalyMs. Steneberg isExperienced. Learn about Holoprosencephaly.
- Maturity Onset Diabetes of the YoungMs. Steneberg isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Type 2 Diabetes (T2D)Ms. Steneberg isExperienced. Learn about Type 2 Diabetes (T2D).